Author:
Miskulin Dana C.,Tangri Navdeep,Bandeen-Roche Karen,Zhou Jing,McDermott Aidan,Meyer Klemens B.,Ephraim Patti L.,Michels Wieneke M.,Jaar Bernard G.,Crews Deidra C.,Scialla Julia J.,Sozio Stephen M.,Shafi Tariq,Wu Albert W.,Cook Courtney,Boulware L. Ebony
Publisher
American Society of Nephrology (ASN)
Subject
Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology
Reference49 articles.
1. The DOPPS Practice Monitor for US Dialysis Care: Trends Through December 2011
2. FDA Drug Safety Communication: Modified dosing recommendations to improve the safe use of Erythropoiesis-Stimulating Agents (ESAs) in chronic kidney disease. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm259639.htm. Accessed July 2, 2012
3. The Federal Register 42 CFR Parts 410, 413 and 414 Medicare Program; End-Stage Renal Disease Prospective Payment System; Final Rule and Proposed Rule. Available at: http://www.gpo.gov/fdsys/pkg/FR-2010-08-12/pdf/2010-18466.pdf. Accessed July 2, 2013
4. Iron Overload in Haemodialysis Patients Increases the Risk of Bacteraemia: A Prospective Study
5. Iron and Virulence in the Family Enterobacteriaceae
Cited by
62 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献